Enzyme catalyzed biotransformation of the energetic chemical octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX) is not known. The present study describes a xanthine oxidase (XO) catalyzed biotransformation of HMX to provide insight into the biodegradation pathway of this energetic chemical. The rates of biotransformation under aerobic and anaerobic conditions were 1.6 AE 0.2 and 10.5 AE 0.9 nmol h À1 mg protein À1 , respectively, indicating that anaerobic conditions favored the reaction. The biotransformation rate was about 6-fold higher using NADH as an electron-donor compared to xanthine. During the course of reaction, the products obtained were nitrite (NO À 2 ), methylenedinitramine (MDNA), 4-nitro-2,4-diazabutanal (NDAB), formaldehyde (HCHO), nitrous oxide (N 2 O), formic acid (HCOOH), and ammonium (NH þ 4 ). The product distribution gave carbon and nitrogen mass-balances of 91% and 88%, respectively. A comparative study with native-, deflavo-, and desulfo-XO and the site-specific inhibition studies showed that HMX biotransformation occurred at the FAD-site of XO. Nitrite stoichiometry revealed that an initial single N-denitration step was sufficient for the spontaneous decomposition of HMX. Crown Copyright Ó 2003 Published by Elsevier Science (USA). All rights reserved.
Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX) is a widely used energetic chemical for military and commercial purposes. The high scale manufacture, use, and disposal of this chemical have resulted in alarming levels of soil and groundwater contamination [1, 2] . HMX is toxic to the biological systems and human health [3] [4] [5] [6] [7] . Hence there is a need for its safe removal from the contaminated sites. Several reports are available regarding biodegradation of HMX under aerobic [8] and anaerobic [9] [10] [11] conditions. However, no literature is available so far in regard to the enzymatic biotransformation of HMX. Such information is necessary to understand the mechanism(s) of biodegradation of RDX and HMX in anaerobic environments such as marine/estuarine water and sediments and thus to optimize the process for its mineralization. Unlike nitroaromatic compounds, cyclic nitramines lack aromatic electronic stability. Therefore, an initial enzymatic or chemical attack on one of its N-NO 2 or -CH 2 -groups should be sufficient for the ring cleavage and subsequent decomposition [12, 13] .
Xanthine oxidase (EC 1.1.3.22) is a metallo-flavo enzyme composed of two identical subunits, each subunit has a mol. wt. of 145 kDa and contains one each of molybdenum-site and FAD-site and two Fe-S centers [14] . Although XO has broad specificity for a wide variety of substrates, its physiological role is believed to be in purine catabolism where it catalyzes the oxidation of hypoxanthine to xanthine and then xanthine to uric acid with concomitant reduction of molecular oxygen [14] . In recent years, much attention has been given to XO catalyzed reduction of inorganic nitrate and nitrite in regard to pathogenesis of ischemia/reperfusion injury in mammals [15] [16] [17] [18] . The present, in vitro, study could provide an understanding about how organisms that produce XO or similar enzyme(s) biotransform and thus counter the toxic effects of cyclic nitramine compounds such as HMX in the environment. To the best of our knowledge, no study has been reported so far in regard to the XO catalyzed biotransformation of a cyclic nitramine compound. The presents study describes the initial reaction(s) involved in the biotransformation of HMX catalyzed by xanthine oxidase (XO). Several enzyme-modifications and site-specific inhibition studies were carried out in order to gain insights into the involvement of specific redox-center(s) of XO in the biotransformation of HMX. Carbon and nitrogen mass-balances, and product stoichiometry were also determined and a biotransformation mechanism is proposed.
Materials and methods
Chemicals. Commercial grade HMX (purity >99 %) was provided by the Defense Research and Development Canada (DRDC), Valcartier, Que., Canada. 4-Nitro-2,4-diazabutanal was obtained from SRI International, Menlo Park, CA, USA. Methylenedinitramine (MDNA) was obtained from the rare chemical department of Aldrich, Oakville, Ont., Canada. Other chemicals, i.e., NADH, xanthine, uric acid, flavin adenine dinucleotide (FAD), allopurinol, diphenyleneiodonium chloride (DPI), and formaldehyde were purchased from Sigma Chemicals, Canada. Standard nitrous oxide (N 2 O, 980 ppm by mole) was obtained from Scott specialty gases, Sarnia, Ont., Canada.
Enzyme preparation. Xanthine oxidase (EC 1.1.3.22) from buttermilk was obtained from Sigma chemicals, Canada. The enzyme suspension was mixed with five volumes of potassium phosphate buffer (50 mM, pH 7.0) and filtered through a Biomax-5K membrane (Sigma chemicals) twice before resuspending in the same buffer. The protein concentration was measured by bicinchoninic acid (BCA) kit (Sigma Chemicals) as per company instructions using bovine serum albumin as standard. The native xanthine oxidase (XO) activity was estimated using the standard method by measuring the increase in absorbance at 295 nm as a function of rate of oxidation of xanthine to uric acid.
Enzyme modifications and reconstitution. The deflavo-and reconstituted-XO were prepared as described by Komai et al. [19] . Reconstitution was carried out by incubating the deflavo-XO with 200 lM FAD in a potassium phosphate buffer (50 mM, pH 7.0) for 1 h at 30°C. The unbound FAD was removed by washing the enzyme with the same buffer using Biomax-5K membrane centrifuge filter units. Preparation of desulfo-XO and its subsequent reactivation were done by the methods described by Massey and Edmondson [20] . The reactivation of desulfo-XO was performed by incubating it with a 10 mM solution of Na 2 S at 30°C in a potassium phosphate buffer (50 mM, pH 7.0) for 90 min. After incubation period, the free Na 2 S was removed as described above.
Biotransformation assays. HMX biotransformation by the native-, desulfo-, and deflavo-forms of xanthine oxidase was performed under both aerobic (in the presence of air) and anaerobic conditions in 6 ml glass vials. Anaerobic conditions were created by purging all the solutions with argon three times (10 min each time at 10 min intervals) and replacing the headspace air with argon in a sealed vial. Each assay vial had 1 ml of an assay mixture containing HMX (40 lM), NADH (150 lM) or xanthine (150 lM), and xanthine oxidase (1 mg ml À1 ) in a potassium phosphate buffer (50 mM), pH 7.0. Reactions were performed at 30°C. Three different controls were prepared by omitting either enzyme, NADH or both from the assay mixture. Samples from the liquid and gas phase in the vials were withdrawn periodically to analyze for HMX and the biotransformed products as described in analytical procedures (discussed below). NADH was determined as described previously [12] . HMX biotransformation activity of the enzyme was expressed as nmol h À1 mg protein À1 unless otherwise stated. In order to detect and quantify the HMX metabolites which were produced in trace amounts, the energetic chemical was added to the reaction mixture at a final concentration of 11.8 mg L À1 (above saturation level) from a 10,000 mg L À1 stock solution made in acetone. The aqueous solubility of HMX at 25°C has been reported as 6.6 mg L À1 [21] . Biotransformation of the intermediates. In order to determine the fate of transient HMX intermediates, i.e., methylenedinitramine (40 lM), 4-nitro-2,4-diazabutanal (40 lM), and HCHO (100 lM), the standard intermediates were incubated separately with XO under the same experimental conditions as used for the biotransformation of HMX under anaerobic conditions. Samples from the liquid and gas phase in the vials were withdrawn periodically to analyze the residual compound and the biotransformed products as described in analytical procedures.
Enzyme inhibition studies. This study was performed by incubating XO with increasing concentrations of site-specific inhibitors, i.e., allopurinol or DPI for 30 min at room temperature. Thereafter, HMX biotransformation activity of the treated enzyme was determined by using two different electron-donors, i.e., NADH and xanthine. The nitrite mediated inhibition of HMX biotransformation was determined by assaying the XO against HMX in the presence of increasing NaNO 2 concentrations. The type of inhibition was inferred from the standard Lineweaver-Burk plots.
Analytical procedures. HMX and its nitroso-derivatives, i.e., octahydro-1-nitroso-3,5,7-trinitro-1,3,5,7-tetrazocine, octahydro-1,3-dinitroso-5,7-dinitro-1,3,5,7-tetrazocine, octahydro-1,5-dinitroso-3,7-dinitro-1,3,5,7-tetrazocine, octahydro-1,3,5-trinitroso-7-nitro-1,3,5, 7-tetrazocine, and octahydro-1,3,5,7-tetranitroso-1,3,5,7-tetrazocine were analyzed by LC/MS as described previously [10, 11] .
Methylenedinitramine and 4-nitro-2,4-diazabutanal were analyzed and quantified by a Waters HPLC system equipped with a photodiode array (PDA) detector (model 2996), a model 600 pump, a model 717 plus injector, and a temperature control module. A 50 ll of sample was injected. The separation was made on an interaction chromatography ION-310 column (15 cm Â 6.5 mm) supplied by Cobert Associates, St. Louis, MO, USA. The mobile phase was an acidified water (385 ll sulfuric acid in 4 L of deionized water, pH 2.0) at a flow rate of 0.6 ml min À1 and 35°C. The detector was set to scan from 200 to 3250 nm wavelength and chromatograms were extracted at a wavelength of 225 nm.
Nitrite (NO À 2 ), ammonium (NH þ 4 ), formaldehyde (HCHO), and nitrous oxide (N 2 O) were analyzed by the previously reported methods [12, 13, 22] . Formic acid (HCOOH) was measured using an HPLC from Waters (pump model 600 and an autosampler model 717 plus) equipped with a conductivity detector (model 430). The separation was made on a DIONEX IonPac AS15 column (2 Â 250 mm). The mobile phase was 30 mM KOH at a flow rate of 0.4 ml min À1 and 40°C. The detection of formic acid was enhanced by reducing the background with an autosuppressor from ALTECH (model DS-Plus) and the detection limit was 100 ppb (parts per billion).
Results and discussion
Biotransformation, mass-balance, and product stoichiometry of HMX Xanthine oxidase biotransformed HMX, using NADH as electron-donor, under aerobic and anaerobic conditions at the rates of 1.6 AE 0.2 and 10.5 AE 0.9 nmol h À1 mg protein À1 , respectively, indicating that anaerobic conditions favored the reaction. Hence the subsequent study was carried out under anaerobic conditions.
In a time-course, HMX disappearance was accompanied by the formation of nitrite (NO (Fig. 1) . Methylenedinitramine (MDNA) and 4-nitro-2,4-diazabutanal (NDAB) were detected as transient metabolites and ammonium (NH þ 4 ) was an end-product (Table 1) .
XO also biotransformed HMX metabolites, i.e., NDAB and HCHO. For example, when standard compounds of NDAB and HCHO were incubated with XO under the same reaction conditions as those used for HMX, both compounds were biotransformed at the rates of 8.0 AE 0.6 and 16.5 AE 1.4 nmol h À1 mg protein À1 , respectively. The NDAB produced N 2 O, NH þ 4 , and HCOOH whereas HCHO was biotransformed to HCOOH quantitatively (data not shown). It is known that XO utilizes water (H 2 O) as a source of oxygen during biotransformation of HCHO to HCOOH [14] . On the other hand, standard MDNA was readily decomposed abiotically at a rate of 9.2 AE 0.7 nmol h À1 under similar reaction conditions. It has previously been reported that MDNA decomposes abiotically to produce N 2 O and HCHO [23] . None of the nitroso-derivatives of HMX were observed during the course of reaction.
Some of the HMX products observed in the present study are consistent with those detected in our previous studies with HMX [11, 24] and RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) [12, 13, 22, 25] . Biodegradation of HMX with anaerobic sludge produced an array of products including nitroso-derivatives of HMX, methylenedinitramine, formaldehyde, nitrous oxide, nitrogen, and carbon dioxide [11] . Recently, we observed nitrite, nitrous oxide, 4-nitro-2,4-diazabutanal, and formaldehyde during alkaline hydrolysis of HMX [24] . The 4-nitro-2,4-diazabutanal, besides being a HMX metabolite in the present study, was also a major product during biotransformation of RDX by cytochrome P450 [13] and Rhodococcus sp. DN22 [25] . On the other hand, methylenedinitramine was a major transient metabolite produced during RDX biotransformation by a diaphorase from Clostridium kluyveri [12] and nitrate reductase from Aspergillus niger [22] .
The total carbon and nitrogen mass-balances in the present study were 91% and 88%, respectively (Table 1) . Numerically, of the 4.0 carbon atoms per HMX molecule, 3.3 were recovered in forms of HCHO and HCOOH. On the other hand, of the 8 nitrogen atoms per HMX molecule, 6 were recovered in forms of NO 
Involvement of FAD-site in HMX biotransformation
Xanthine oxidase has three redox-cofactors: the FAD-site, the molybdenum-site, and the two Fe-S centers (Fig. 2) . The molybdenum-site interacts with a variety of substrates such as xanthine, inorganic nitrate, and nitrite [18] , and aldehydes [14] whereas the FADsite reduces oxygen [14] and organic nitrates [17] . Xanthine and NADH donate electrons at molybdenum-site and FAD-site, respectively (Fig. 2) .
Chemically modified XO (deflavo-and desulfo-XO) were used in order to determine the reaction site for HMX biotransformation. In an experiment with deflavo-XO, both NADH and xanthine-dependent HMX biotransformations were inhibited (Table 2) , indicating the direct involvement of FAD-site in HMX biotransformation. Furthermore, upon reconstitution of deflavo-XO with a 200 lM of FAD, both NADH and xanthine-dependent HMX biotransformation activities were restored up to 78% (Table 2) , providing an additional support for the involvement of FAD-site in HMX biotransformation. On the other hand, in desulfo-XO, there was no significant change in HMX biotransformation activity when NADH was used as electron-donor, however, no activity was observed using xanthine as electron-donor (Table 2 ). This experiment indicated that HMX biotransformation did not occur at molybdenum-site of XO. Previously, Doel et al. [17] demonstrated that glyceryl trinitrate was biotransformed at FAD-site of XO with concomitant release of nitrite when the reaction was performed under anaerobic conditions using xanthine as an electron-donor.
The rate of HMX biotransformation by the native-XO was about 6-fold higher with NADH compared to xanthine as an electron-donor ( Table 2 ). The most plausible reason may be the interaction of NADH and HMX at the same site (i.e., FAD-site) of XO for donating and accepting electrons, respectively, which led to a higher reaction rate. In contrast, the xanthine donates electrons at the molybdenum-site which subsequently transfers them to the FAD-site. The latter finally transfers the electron to HMX. This multi-step electron-transfer process probably decreases the resultant reaction rate.
Site-specific inhibition studies DPI acts at FAD-site and prevents NADH from donating electrons at the site [19] whereas allopurinol binds at molybdenum-site and prevent its participation in electron transfer reactions [26] . In the present study, DPI inhibited the XO catalyzed biotransformation of HMX in a concentration-dependent manner (Fig. 3) whereas allopurinol did not inhibit the same reaction using NADH as electron-donor (Fig. 3) . This experiment proved that HMX biotransformation occurred at the FAD-site and not the molybdenum-site. On the other hand, when xanthine was used as an electron-donor instead of NADH, both DPI and allopurinol inhibited the HMX biotransformation (data not shown) which additionally supported that FAD-site is the site of reaction.
Lineweaver-Burk plots showed that nitrite was a non-competitive inhibitor of HMX biotransformation (Fig. 4) which indicated that nitrite and HMX bind at different sites on XO, although they share a common electron source, NADH. Since nitrite binds at the molybdenum-site for its reduction [15, 16, 18] therefore Fig. 2 . A schematic representation of redox-cofactors present in xanthine oxidase (modified scheme from Komai et al. [19] ) showing the interaction-sites for various electron-donors and site-specific inhibitors. Mo-site is molybdenum-site. Arrows indicate the direction of flow of electrons. HMX must bind at the FAD-site in order to accept electron. Several lines of evidence have proved that biotransformation of HMX occurred at FAD-site. The present study is analogous with a previous report [17] which also showed the reduction of organic nitrates at FAD-site of xanthine oxidoreductase under anaerobic conditions.
Proposed biotransformation mechanism
Based on the above data, we propose that HMX undergoes a single N-denitration which requires an initial obligatory one electron transfer step. In the present study, the electron transfer reaction occurred at the FAD-site which is known to catalyze one electron transfer to O 2 [14, 19] . Therefore, under aerobic conditions, O 2 and HMX compete for the common bindingsite (i.e., FAD-site) which accounts for the 6.5-fold lower HMX biotransformation rate in the presence of O 2 . On the other hand, under anaerobic conditions, XO could catalyze one electron transfer to HMX followed by a single N-denitration which eventually formed hypothetical structure I (Fig. 5) . The structure I is analogous to the one we proposed during RDX biotransformation by cytochrome P450 [13] . The hypothetical structure I, being unstable, underwent hydrolytic decomposition to first produce structure II followed by ring cleavage to produce structure III (Fig.  5) . The spontaneous hydrolysis of III would produce MDNA and NDAB (Fig. 5) . As mentioned above, the NDAB was further biotransformed by XO to their respective products (i.e., N 2 O, NH þ 4 , and HCOOH) whereas MDNA was abiotically decomposed to N 2 O and HCHO. The latter being a substrate of XO was also partly biotransformed to HCOOH (mentioned above).
In a previous report, Chapman et al. [27] demonstrated a chemical N-denitration of HMX using a net hydride transfer agent, 1-benzyl-1,4-dihydronicotinamide, in a photochemical reactor having a 200-W tungsten light bulb. They proposed that all the four N-NO 2 bond scissions occurred to produce a corresponding amine (octahydro-1,3,5,7-tetrazocine). The latter was unstable and underwent rearrangement to produce a more stable product hexamethylenetetramine [27] . In contrast, we observed a single N-denitration of HMX leading to its spontaneous decomposition (Table 1) . Hence the present study apparently favors the XO catalyzed one electron transfer to HMX instead of a hydride transfer.
Several experimental evidences such as oxygen-sensitivity of the reaction, involvement of FAD-site in HMX biotransformation, and a stoichiometric single Ndenitration of HMX have proved that XO catalyzed a one-electron transfer to HMX at FAD-site, necessary to cause a single N-denitration, leading to spontaneous decomposition.
In conclusion, we provided the first biochemical evidence of XO catalyzed biotransformation of HMX under anaerobic conditions. The mechanism described here is consistent with our previous results regarding enzymatic biotransformation of RDX [12, 13] which also proved that one-electron transfer is necessary and sufficient to cause single N-denitration of RDX. The 4-nitro-2,4-diazabutanal, previously produced and accumulated during biodegradation of RDX with Rhodococcus sp. DN22 [25] , was further biotransformed in the present study. This observation encourages one to use XO or similar enzyme(s) producing microorganisms for the complete degradation of RDX and HMX to innocuous products without accumulation of intermediates. The present study extends the fundamental knowledge to understand the biotransformation mechanism(s) of cyclic nitramine energetic compounds so as to design and optimize a well-controlled biochemical reaction for the complete mineralization of these compounds in soil and sediments.
